MONTREAL, QC – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is deeply disappointed with the draft recommendations of the Canadian Drug Expert Committee (CDEC) issued by the Canadian Agency for Drugs… Read More
WELL achieved record annual revenue of $776.1 million for 2023, an increase of 36% compared to the prior year. WELL achieved record quarterly revenues of $231.2 million in Q4-2023, an… Read More
ADPKD is the most common inherited kidney disease, with no treatments currently available that address the underlying cause of disease Vertex to initiate a Phase 1 clinical trial in healthy… Read More
Celebrating 120 years of pioneering healthcare, Getinge reflects on its journey in the industry. With a strong focus on continuous improvement and innovation, the global medtech company stays committed to… Read More
Evonik selected for high-quality Cell Culture Solutions Award celebrates innovation in biopharmaceutical technologies Portfolio expansion and strengthening of application and formulation competence with biosolutions Evonik has been awarded an Asia-Pacific… Read More
